Serotherapy of avian reticuloendotheliosis virus-induced tumors.
Immune serum, obtained from animals that had survived sublethal challenge with RE virus, was very effective in achieving tumor cures in chickens infected with this virus. The therapeutic effect could also be obtained by the immunoglobulin fraction of immune serum. The serum did not influence the development of an unrelated malignancy. Serotherapy studies in Bx and Tx recipients indicate that the B-cell or T-cell system of the host does not significantly contribute to the curative activity of immune serum. Absorption studies show that the curative effect is mediated by antibodies to tumor-associated transplantation antigens on tumor cells, not by antiviral antibodies.
D000818:Animals; D000912:Antibodies, Neoplasm; D000914:Antibodies, Viral; D000917:Antibody Formation; D001402:B-Lymphocytes / Q000276:immunology; D002060:Bursa of Fabricius / Q000601:surgery; D002645:Chickens; D007106:Immune Sera; D007116:Immunization, Passive; D008380:Marek Disease / Q000276:immunology; D001356:Reticuloendotheliosis virus; D055761:Reticuloendotheliosis, Avian / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D012190:Retroviridae; D013601:T-Lymphocytes / Q000276:immunology; D013934:Thymectomy; D005719:gamma-Globulins / Q000276:immunology
D000912:Antibodies, Neoplasm; D000914:Antibodies, Viral; D007106:Immune Sera; D005719:gamma-Globulins